Multi-symptom asthma as an indication of disease severity in epidemiology by unknown
POSTER PRESENTATION Open Access
Multi-symptom asthma as an indication of
disease severity in epidemiology
Linda Ekerljung1, Apostolos Bossios2, Jan Lötvall2, Anna-Carin Olin3, Eva Rönmark4, Göran Wennergren5,
Kjell Torén3, Bo Lundbäck2*
From EAACI International Severe Asthma Forum (ISAF 2012)
Gothenburg, Sweden. 11-13 October 2012
Epidemiological questionnaires have failed to identify indi-
viduals with severe asthma. The extent of symptoms of
asthma can, however, easily be established in epidemiolo-
gical studies by identification of multiple symptoms. We
hypothesized that reporting of multiple symptoms of
asthma reflects uncontrolled disease and can be a sign of
more severe asthma. The aims of the current study were,
therefore, to determine the prevalence and determinants
of multi-symptom asthma. In this paper we report our
definition of multi-symptom asthma and its clinical char-
acteristics. A postal questionnaire was mailed to 30,000
randomly selected subjects aged 16–75 yrs. A subgroup
underwent detailed clinical examinations including lung
function test, exhaled NO, methacholine test in addition
to a detailed clinical history by using structured interview.
Multi-symptom asthma was defined as questionnaire
reported physician-diagnosed asthma, use of asthma medi-
cation, recurrent wheeze, attacks of shortness of breath,
and at least one additional respiratory symptom. The over-
all prevalence of physician-diagnosed asthma was 8.3%,
while of multi-symptom asthma the prevalence was
2.0% (women 2.4%, men 1.5%, p < 0.001). Multi-symptom
asthma versus other asthma was associated with lower
FEV1 (88.8% pred vs. 98.8% pred), higher FeNO (29.3 ppb
vs. 23.2 ppb), a greater proportion having PD20 < 1.96 mg
methacholine chloride (82.9% vs. 58.7%), all statistically
highly significant. The same pattern was found for asthma
exacerbations, emergency department visits and hospitali-
zations. All respiratory symptoms were more common in
multi-symptom asthma compared with other asthma, and
that was true also for symptoms of bronchitis, rhinitis and
rhino-sinusitis. In contrast, allergic rhinitis and allergic
sensitization were not more common in multi-symptoms
asthma than in other asthma. Multi-symptom asthma can-
not be used for defining severe asthma. We conclude,
however, that multi-symptom asthma, as we defined the
condition, is related to signs of more severe disease and
could be used as an epidemiological marker of asthma
severity.
Author details
1University of Gothenburg, Sweden. 2University of Gothenburg, Institute of
Medicine/Krefting Research Centre, Sweden. 3University of Gothenburg,
Institute of Medicine/Dept of Occup & Envir Med, Sweden. 4University of
Umeå, Dept of Public Health & Clinical Medicine, Sweden. 5University of
Gothenburg, Dept of Pediatrics, Sweden.
Published: 3 May 2013
doi:10.1186/2045-7022-3-S1-P6
Cite this article as: Ekerljung et al.: Multi-symptom asthma as an
indication of disease severity in epidemiology. Clinical and Translational
Allergy 2013 3(Suppl 1):P6.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color figure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
2University of Gothenburg, Institute of Medicine/Krefting Research Centre,
Sweden
Full list of author information is available at the end of the article
Ekerljung et al. Clinical and Translational Allergy 2013, 3(Suppl 1):P6
http://www.ctajournal.com/content/3/S1/P6
© 2013 Ekerljung et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited.
